🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study was to evaluate the safety and efficacy of ligeli...
Status
Completed
Location
Novartis Investigative Site
Start Date
2019-04-13
Trial ID
NCT03907878
Treatments Being Tested
The study will assess the safety and efficacy of QGE031 in the treatment of...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-01-05
Trial ID
NCT01552629
Treatments Being Tested
Global Cohort Managed Access Program (MAP) to provide access to ligelizumab...
Status
No Longer Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT04903613
Treatments Being Tested
This was a placebo controlled, phase 3 study designed to evaluate the effic...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2021-11-16
Trial ID
NCT05024058
Treatments Being Tested
The purpose of this study was to establish efficacy and safety of ligelizum...
Status
Completed
Location
Allervie Clinical Research
Start Date
2018-10-20
Trial ID
NCT03580356
Treatments Being Tested
This is a placebo and active-controlled phase 2b dose-finding study to eval...
Status
Completed
Location
Novartis Investigative Site
Start Date
2015-07-15
Trial ID
NCT02477332
Treatments Being Tested
This study planned to assess long-term safety of QGE031 during 12 months tr...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2014-03-27
Trial ID
NCT02075008
Treatments Being Tested
A safety extension study to evaluate the long-term safety of QGE031 240 mg ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2016-05-24
Trial ID
NCT02649218
Treatments Being Tested
This study planned to assess the effect on the reduction in rate of severe ...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2015-09
Trial ID
NCT02336425
The purpose of this extension study was to establish efficacy and safety of...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2020-04-08
Trial ID
NCT04210843
Treatments Being Tested